Raykov Rosty bought FENC
June 1, 2026 · Form 4 insider transaction
Raykov Rosty bought 15,597 shares of Fennec Pharmaceuticals Inc. at $2.45 per share, a transaction worth $38.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
15,597
Price
$2.45
Total value
$38.2K
InsiderRaykov Rosty
RoleDirector
SecurityCommon shares
Transaction codeM: Option exercise
Transaction dateJune 1, 2026
Filing dateJune 2, 2026
Shares owned after139,826
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025.